Rockwell Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Rockwell Medical
RMTI Stock  USD 1.00  0.12  10.71%   
Rockwell Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Rockwell Medical's valuation are provided below:
Gross Profit
11.4 M
Profit Margin
(0.07)
Market Capitalization
44.1 M
Enterprise Value Revenue
0.4439
Revenue
75.6 M
We have found one hundred twenty available trending fundamental ratios for Rockwell Medical, which can be analyzed and compared to other ratios and to its competitors. Traders should compare all of Rockwell Medical recent fundamentals against the fundamentals between 2010 and 2026 to make sure the company is sustainable this year. The Rockwell Medical's current Market Cap is estimated to increase to about 93 M. The Rockwell Medical's current Enterprise Value is estimated to increase to about 87 M

Rockwell Medical Total Revenue

122.55 Million

Check Rockwell Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Rockwell Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Interest Expense of 1.4 M or Total Revenue of 122.5 M, as well as many indicators such as Price To Sales Ratio of 0.68, Dividend Yield of 0.0 or PTB Ratio of 1.66. Rockwell financial statements analysis is a perfect complement when working with Rockwell Medical Valuation or Volatility modules.
  
Build AI portfolio with Rockwell Stock
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.

Rockwell Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets38.3 M68.1 M53.2 M
Pretty Stable
Short and Long Term Debt Total16.3 M15.6 M10.2 M
Slightly volatile
Other Current Liabilities10.4 M9.9 M6.6 M
Slightly volatile
Total Current Liabilities9.9 M16.2 M13.6 M
Pretty Stable
Property Plant And Equipment Net12.5 M11.9 M5.4 M
Slightly volatile
Accounts Payable4.1 M3.3 M4.9 M
Slightly volatile
Cash13.2 M18 M18.1 M
Very volatile
Non Current Assets Total26.8 M25.5 M10.7 M
Slightly volatile
Non Currrent Assets Other1.1 M811.9 K1.6 M
Pretty Stable
Cash And Short Term Investments22 M24.8 M31.5 M
Very volatile
Net Receivables10 M9.5 M6 M
Slightly volatile
Common Stock Shares Outstanding37.5 M35.7 M11 M
Slightly volatile
Liabilities And Stockholders Equity38.3 M68.1 M53.2 M
Pretty Stable
Non Current Liabilities Total9.6 M14.4 M15 M
Pretty Stable
Inventory3.8 M6.6 M4.9 M
Slightly volatile
Other Current Assets1.1 M1.6 M1.6 M
Slightly volatile
Other Stockholder Equity519.5 M494.7 M216.2 M
Slightly volatile
Total Liabilities18.5 M30.6 M27.5 M
Slightly volatile
Property Plant And Equipment Gross25.1 M23.9 M8.7 M
Slightly volatile
Total Current Assets31.4 M42.6 M43.7 M
Very volatile
Short Term Debt1.8 M2.8 M3.3 M
Pretty Stable
Intangible Assets12.3 M11.7 M4.8 M
Slightly volatile
Common Stock Total Equity9.8 K10.3 K98.3 M
Slightly volatile
Other Assets16.7 M15.9 M5.7 M
Slightly volatile
Good Will742 K828.9 K914.6 K
Slightly volatile
Property Plant Equipment10.4 M9.9 M5.3 M
Slightly volatile
Warrants5.1 M4.4 M5.3 M
Slightly volatile
Long Term Debt Total21.6 M20.6 M16.2 M
Slightly volatile
Capital Lease Obligations4.8 M5.5 M3.8 M
Slightly volatile
Other Liabilities2.2 M2.4 M11.8 M
Slightly volatile
Net Invested Capital35 M47.5 M33.4 M
Pretty Stable
Net Working Capital22.1 M20.6 M31.9 M
Slightly volatile
Capital Stock2.6 K2.7 K158.6 M
Slightly volatile
Capital Surpluse384.1 M427.2 M349.2 M
Slightly volatile
Short and Long Term Debt229.1 K241.2 K1.6 M
Pretty Stable

Rockwell Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2.6 M2.5 M1.4 M
Slightly volatile
Total Revenue122.5 M116.7 M65.9 M
Slightly volatile
Other Operating Expenses62.9 M116 M83 M
Slightly volatile
Cost Of Revenue101.4 M96.6 M58.9 M
Slightly volatile
Total Operating Expenses19.6 M19.4 M27.6 M
Slightly volatile
Selling General Administrative12.5 M16.2 M15.6 M
Pretty Stable
Research Development20.8 K21.9 K9.5 M
Slightly volatile
Interest Income78.7 K82.8 K386 K
Slightly volatile
Reconciled Depreciation2.3 M2.5 M1.5 M
Slightly volatile
Selling And Marketing Expenses3.5 M2.5 M2.6 M
Slightly volatile
Non Recurring367.6 K387 K1.3 M
Slightly volatile

Rockwell Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation2.6 M2.5 M1.4 M
Slightly volatile
Capital Expenditures793.4 K1.2 M782.2 K
Pretty Stable
End Period Cash Flow13.3 M18 M18.2 M
Very volatile
Begin Period Cash Flow13 M10.3 M17.4 M
Very volatile
Stock Based Compensation1.1 M1.2 M4.3 M
Slightly volatile
Change To Netincome782.3 K823.5 K5.1 M
Slightly volatile
Issuance Of Capital Stock16.7 M9.2 M20.4 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.680.723.4
Slightly volatile
Days Sales Outstanding42.4434.2935.2911
Very volatile
Average Payables2.5 M3.4 M3.9 M
Pretty Stable
Stock Based Compensation To Revenue0.01390.01460.0769
Slightly volatile
Capex To Depreciation1.00.530.7761
Pretty Stable
EV To Sales0.660.693.2335
Slightly volatile
Inventory Turnover9.8913.0812.6569
Very volatile
Days Of Inventory On Hand36.6628.8734.1386
Very volatile
Payables Turnover27.6726.3514.2841
Slightly volatile
Sales General And Administrative To Revenue0.190.130.2532
Pretty Stable
Average Inventory5.6 M5.3 M4.8 M
Slightly volatile
Research And Ddevelopement To Revenue2.0E-42.0E-40.1885
Slightly volatile
Capex To Revenue0.01090.01150.0225
Slightly volatile
Cash Per Share0.590.636.3187
Slightly volatile
Days Payables Outstanding13.6214.3439.2651
Slightly volatile
Intangibles To Total Assets0.230.220.0844
Slightly volatile
Current Ratio2.62.373.6974
Pretty Stable
Receivables Turnover8.0211.0210.7145
Very volatile
Capex Per Share0.03560.03740.2232
Slightly volatile
Average Receivables3.3 M5.2 M5.1 M
Slightly volatile
Revenue Per Share3.573.7611.4733
Slightly volatile
Interest Debt Per Share0.410.431.4032
Very volatile
Debt To Assets0.140.210.1911
Slightly volatile
Graham Number2.293.323.4102
Pretty Stable
Operating Cycle79.163.1669.4298
Very volatile
Days Of Payables Outstanding13.6214.3439.2651
Slightly volatile
Long Term Debt To Capitalization0.220.190.4503
Slightly volatile
Quick Ratio2.252.03.2897
Pretty Stable
Net Income Per E B T1.081.060.9758
Pretty Stable
Cash Ratio1.091.01.5248
Very volatile
Days Of Inventory Outstanding36.6628.8734.1386
Very volatile
Days Of Sales Outstanding42.4434.2935.2911
Very volatile
Free Cash Flow Operating Cash Flow Ratio1.290.871.0408
Slightly volatile
Fixed Asset Turnover12.418.8318.5005
Slightly volatile
Debt Ratio0.140.210.1911
Slightly volatile
Price Sales Ratio0.680.723.4
Slightly volatile
Asset Turnover1.761.971.3464
Pretty Stable

Rockwell Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap93 M57 M159.7 M
Slightly volatile
Enterprise Value87 M55.1 M149.3 M
Slightly volatile

Rockwell Fundamental Market Drivers

Forward Price Earnings59.1716
Cash And Short Term Investments21.6 M

Rockwell Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Rockwell Medical Financial Statements

Investors use fundamental indicators, such as Rockwell Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Rockwell Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue164.4 K156.2 K
Total Revenue116.7 M122.5 M
Cost Of Revenue96.6 M101.4 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.13  0.19 
Capex To Revenue 0.01  0.01 
Revenue Per Share 3.76  3.57 
Ebit Per Revenue 0.01  0.01 

Currently Active Assets on Macroaxis

FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill
CSANCosan SA ADR
RKTRocket Companies
When determining whether Rockwell Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Rockwell Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Rockwell Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Rockwell Medical Stock:
How To Invest In Rockwell
Details
Is Rockwell Stock a good investment?
Details
What is Rockwell Medical's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Drug Manufacturers - Specialty & Generic Companies
View
Check out the analysis of Rockwell Medical Correlation against competitors.
For more detail on how to invest in Rockwell Stock please use our How to Invest in Rockwell Medical guide.
You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is there potential for Health Care Equipment & Supplies market expansion? Will Rockwell introduce new products? Factors like these will boost the valuation of Rockwell Medical. Anticipated expansion of Rockwell directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Rockwell Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.18)
Revenue Per Share
2.201
Quarterly Revenue Growth
(0.44)
Return On Assets
(0.05)
Return On Equity
(0.17)
The market value of Rockwell Medical is measured differently than its book value, which is the value of Rockwell that is recorded on the company's balance sheet. Investors also form their own opinion of Rockwell Medical's value that differs from its market value or its book value, called intrinsic value, which is Rockwell Medical's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Rockwell Medical's market value can be influenced by many factors that don't directly affect Rockwell Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Rockwell Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Rockwell Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Rockwell Medical's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY